Mustang Bio (MBIO) Assets (2016 - 2026)
Mustang Bio (MBIO) posted quarterly Assets of $16.6 million for Q1 2026, up 11.22% year-over-year from $14.9 million in Q1 2025, and down 5.75% quarter-over-quarter from $17.6 million in Q4 2025.
Mustang Bio (MBIO) Assets (2016 - 2026) Analysis & Trends
Mustang Bio (MBIO) has reported Assets for 11 consecutive years, with $16.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 11.22% year-over-year to $16.6 million; the TTM figure through Mar 2026 stood at $16.6 million (up 11.22% YoY), while the FY2025 annual figure was $17.6 million, up 89.01% from the prior year.
- Assets retreated to $16.6 million in Q1 2026 per MBIO's latest filing, from $17.6 million in the prior quarter.
- Across five years, Assets topped out at $137.0 million in Q1 2022 and bottomed at $7.2 million in Q3 2024.
- Historically, Assets has averaged $42.5 million across 5 years, with a median of $17.7 million in 2023.
- Annual changes were most pronounced in 2023 — Assets plunged 81.1% — and 2025, when it jumped 169.16%.
- Mustang Bio's Assets stood at $92.4 million in 2022, then tumbled by 80.8% to $17.7 million in 2023, then slumped by 47.54% to $9.3 million in 2024, then jumped by 89.01% to $17.6 million in 2025, then slipped by 5.75% to $16.6 million in 2026.
- Business Quant data shows MBIO's Assets at $16.6 million in Q1 2026, $17.6 million in Q4 2025, and $19.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 19.82 Bn |
| 10 | Mustang Bio | 3.87 Mn | 3.87 Mn | - | 15.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.61 Mn |
| Mar 31, 2026 | 16.58 Mn |
| Dec 31, 2025 | 17.59 Mn |
| Sep 30, 2025 | 19.36 Mn |
| Jun 30, 2025 | 13.05 Mn |
| Mar 31, 2025 | 14.91 Mn |
| Dec 31, 2024 | 9.31 Mn |
| Sep 30, 2024 | 7.19 Mn |
| Jun 30, 2024 | 8.52 Mn |
| Mar 31, 2024 | 14.59 Mn |
| Dec 31, 2023 | 17.74 Mn |
| Sep 30, 2023 | 20.57 Mn |
| Jun 30, 2023 | 29.09 Mn |
| Mar 31, 2023 | 73.61 Mn |
| Dec 31, 2022 | 92.42 Mn |
| Sep 30, 2022 | 108.84 Mn |
| Jun 30, 2022 | 121.91 Mn |
| Mar 31, 2022 | 136.96 Mn |
| Dec 31, 2021 | 125.17 Mn |
| Sep 30, 2021 | 134.71 Mn |